Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
Results
|
Expensive Performer
488.2000
3.35
(
0.69
%)
NSE
May 08, 2026
15:31 PM
56.46% Fall from 52W High
Volume:
2.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
10 May 2022, 12:00AM
Results
488.20
0.69%
Suven Pharmaceuticals
Hold:
Cohance Lifesciences Ltd.
by
ICICI Direct
Target: 555
ICICI Direct
Cohance Lifesciences Ltd. is trading
below its 150 day SMA
of 505.3
More from Cohance Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - May 8, 2026
The Baseline |
08 May 2026
Market closes lower amid rising tensions in the Strait of Hormuz
Trendlyne Marketwatch |
08 May 2026
What drove multibaggers in FY26: Order books, commodity cycles and turnaround plays
The Baseline |
07 May 2026